Migdal Insurance & Financial Holdings Ltd. Myriad Genetics Inc Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$25.39 - $32.61 $922,215 - $1.18 Million	-36,322 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$19.92 - $31.6 $448,996 - $712,264	22,540 Added 163.55%	36,322 $1.11 Million
Q4 2020 Feb 08, 2021	BUY	$12.16 - $19.77 $167,589 - $272,470	13,782 New	13,782 $273,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$235 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$160 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$104 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$80.2 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$72.9 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account